(Q45195373)

10 December 2017

title

Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment (English)

1 reference

10 December 2017

1 reference

Jonathan Berman

1

1 reference

10 December 2017

publication date

1 January 2005

1 reference

Current infectious disease reports

10 December 2017

published in

1 reference

10 December 2017

volume

7

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

33-38

1 reference

Placebo-Controlled Clinical Trial of Sodium Stibogluconate (Pentostam) versus Ketoconazole for Treating Cutaneous Leishmaniasis in Guatemala

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0021-1

Worldwide increasing risk factors for leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0021-1

Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0021-1

The epidemiology and control of leishmaniasis in Andean countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-005-0021-1

Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study

21 January 2018

1 reference

12 December 2020

Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study

1 reference

12 December 2020

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

1 reference

12 December 2020

Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer

1 reference

12 December 2020

Diagnosis of cutaneous leishmaniasis in Colombia: the sampling site within lesions influences the sensitivity of parasitologic diagnosis.

1 reference

12 December 2020

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

1 reference

12 December 2020

A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan

1 reference

12 December 2020

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

1 reference

12 December 2020

Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure?

1 reference

12 December 2020

Update: Cutaneous leishmaniasis in U.S. military personnel--Southwest/Central Asia, 2002-2004.

1 reference

12 December 2020

A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel

1 reference

12 December 2020

Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya

1 reference

12 December 2020

PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia).

1 reference

12 December 2020

Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis.

1 reference

12 December 2020

Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India

1 reference

12 December 2020

Value of diagnostic techniques for cutaneous leishmaniasis

1 reference

12 December 2020

The natural history of cutaneous leishmaniasis in Guatemala

1 reference

12 December 2020

Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study

1 reference

12 December 2020

Evaluation of PCR for diagnosis of American cutaneous leishmaniasis in an area of endemicity in northeastern Brazil

1 reference

12 December 2020

Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study.

1 reference

12 December 2020

Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent

1 reference

12 December 2020

Oral miltefosine for Indian visceral leishmaniasis

1 reference

12 December 2020

Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial

1 reference

12 December 2020

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

1 reference

12 December 2020

Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala

1 reference

12 December 2020

Miltefosine for new world cutaneous leishmaniasis.

1 reference

12 December 2020

10.1007/S11908-005-0021-1

Identifiers

DOI

1 reference

10 December 2017

1 reference